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ABSTRACT
Introduction Different countries use a variety of methods to manage the new-
born screening data. In this study, we aimed to compare the experiences of the 
selected countries to propose a framework for managing the newborn screening 
data in Iran.
Methods In this comparative study, data were collected using electronic 
databases and the official website of the Department of Health in America, 
England and Australia. Data related to the process of newborn screening in Iran 
were collected using an open-ended questionnaire and reviewing the published 
documents.
Results In this study, a framework for newborn screening data management 
was proposed which consisted of six main areas, namely; objectives, involved 
organisations, data elements, data collection processes, data classification sys-
tems and the methods of controlling data quality.
Conclusion The framework suggested in this study can help to re-organise the 
process of newborn screening with more focus on data management. These data 
can be used in conducting research and setting strategies for improving the qual-
ity of child health in the country.
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INTRODUCTION
One of the main national investments in each country is mon-
itoring the health status of newborns and children in the com-
munity. Since children are at risk of various diseases, such an 
investment may largely improve their health status and as a 
result, the community will move towards a healthier future.1,2 
The newborn screening is one of the approaches that have 
prevented a number of diseases and congenital disorders in 
the past 40 years.3,4 This approach aims to identify a dis-
ease or a disorder before causing irreparable damages. For 
example, genetic disease screening empowers public health 
in identifying inherited diseases and helps to prevent or 
cure such diseases.5 The newborn screening programmes 
have been started in many developed countries since nearly 
three decades ago and today, they are part of the newborn 
health care initiatives. Despite the importance of the newborn 
screening programme, the developing countries have faced 
a number of challenges, such as medical, technical and logis-
tical support when implementing the programme and as a 
result, it has not been conducted in all areas.6,7
In Iran, the centre of endocrine and metabolism research 
has initially implemented the screening programme for con-
genital hypothyroidism in 1998.8 Overtime, the national 
newborn screening programme was developed and now it 
includes screening for congenital hypothyroidism, phenylke-
tonuria and glucose-6-phosphate dehydrogenase deficiency. 
However, the main problem can be seen after diagnosis 
because there is no long-term follow-up of children who have 
been diagnosed with hypothyroidism, particularly when their 
health report shows a normal growth pattern. Moreover, some 
parents refuse to track the health status of their children after 
diagnosis or refuse to receive further treatment after getting a 
normal laboratory result.9
In Iran, like many other countries, there is a healthcare 
referral system composed of primary, secondary and ter-
tiary care. At the primary care level, the health centres at the 
urban and rural areas are the most important organisations 
that have a key role in improving health status and provid-
ing healthcare services. Regarding the newborn screening, 
in addition to hospitals, the selected centres are responsible 
for conducting laboratory tests, collecting data and sending 
them to the specialists in a timely manner. However, there 
are different methods of data collection and reporting which 
have caused unavailability of needed data at the right time 
and right place, as well as increasing the healthcare costs.10 
For example, parents and paediatricians should be informed 
about the abnormal newborn screening results as early as 
possible. However, there might be a delay in confirming the 
lab results or a delay in contacting the families and physi-
cians.11 Therefore, to make screening data available to the 
healthcare providers, these data should be managed in a 
structured manner. Otherwise, the improper management 
of data and a lack of timely follow-up may cause irrevers-
ible damages for the patients and public health. In Iran, all 
data related to the newborn screening are paper-based and 
reported to the department of health of medical universities. 
As the country is moving towards using electronic health 
records and a well-structured paper-based record can be 
a basis for the future electronic health records, this study 
aimed to compare the experiences of the selected countries 
(America, England and Australia) to propose a framework 
for managing newborn screening data in Iran. It is expected 
that defining a framework for recording, storing and sharing 
information helps to increase efficiency and improve health 
management through informed decision making.
METHODS
This was a mixed methods study which was conducted in 
2014. Initially, the data management methods for the new-
born screening were compared in America, England and 
Australia. Data related to the newborn screening systems 
in America, England and Australia were collected through 
searching databases, such as PubMed, Science Direct, 
Scopus, Web of Knowledge and the official websites of the 
Ministry of Health of these countries. The keywords used 
for searching databases included neonatal screening, new-
born screening, newborn screening information system and 
screening information system.
Since there was not any specific system for managing new-
born screening data in Iran, the data were collected by dis-
tributing questionnaires (eight open-ended questions) among 
the experts in the field of newborn screening (n = 20) to know 
about the process of newborn screening and the methods 
of data management. These data were analysed using con-
tent analysis method. Finally, a framework was proposed 
based on the results achieved from the document review and 
experts’ opinions.
RESULTS
As noted before, there was no adequate document about the 
newborn screening data management in Iran. Therefore, a 
questionnaire consisted of eight open-ended questions was 
distributed among 20 participants who worked in the field of 
newborn screening. Table 1 shows the demographic charac-
teristics of the participants.
Having reviewed the related literature in the selected coun-
tries and participants’ opinions in Iran, the main components 
for managing newborn screening data were determined to 
propose a framework. These components included the objec-
tives, involved organisations, data elements, data collection 
process, disease classification systems and the methods of 
data quality control. The details of each component are pre-
sented as follows:
Objectives
The findings showed that the objectives of newborn screening 
programmes were similar in America, England and Australia. 
These objectives included disease prevention, information-
based planning, investigating the causes of infants mortality, 
creating new methods for screening, timely follow-up visits, 
providing a basis for education and research.12–14 Similarly, 
Journal of Innovation in Health Informatics Vol 25, No 4 (2018)
Ayatollahi et al. Newborn screening data management: proposing a framework for Iran 223
in Iran, the objectives of the newborn screening programme 
were patient follow-up, education, information-based plan-
ning and disease prevention.15 Obviously, to achieve these 
objectives, accurate and precise data should be collected 
and managed as valuable information recourse.
Involved organisations
In Australia, the Genetic Association and the Ministry of 
Health were responsible for managing the newborn screening 
data, and the data were collected in each state separately.16 
However, in America and England, the newborn screening 
data were collected at the national level.17,18 In America, a 
number of organisations, such as the Advisory Committee on 
Heritable Disorders in Newborns and Children and National 
Newborn Screening and Genetics Resource Center were 
involved in the process of newborn screening.17 In England, 
Primary Care Trusts, UK Newborn Screening Programme 
Centre, UK National Screening Committee and Public Health 
England were among the organisations that are involved 
in the process of newborn screening. In Iran, the newborn 
screening data related to hypothyroidism disease were col-
lected at the national level and the Ministry of Health was 
the only organisation responsible for implementing newborn 
screening programmes.19
Data elements
According to the findings, different data elements were col-
lected during the newborn screening. The data related to a 
newborn (gender, birth weight, birth time and birth order), a 
mother (name, date of birth and gestational age), screen-
ing tests (the name of the laboratory, the date of sampling 
and test results), service provider centre (the name of the 
primary care centre, place of birth and name of the hospi-
tal) and service providers in screening centres (the name of 
the doctors) were collected and recorded in newborn screen-
ing cards in America, England and Australia.20–24 In England 
and Australia, the parents’ consent form was attached to the 
blood sample card.22,23 Only in Australia, a separate consent 
form was completed.23 Generally, a comparison between the 
number of newborn screening data elements in the above-
mentioned three countries showed that in England, the 
number of collected data elements was more than in other 
countries. In Iran, the demographic information of a newborn, 
date of sampling, the name of the primary care and the sam-
pling centre, newborn’s father’s name, the number of Guthrie 
paper, screening test results and the date of test results are 
recorded.25
Data collection process
The results showed that the process of collecting and record-
ing newborn screening data in electronic patient records were 
similar in America, England and Australia.22–24 In America 
and Australia, the newborn screening data were kept in 
laboratories.23,24 In Australia, there was a central database 
to store the test results.23 In England, electronic systems 
and data collection forms were used for collecting newborn 
screening data.22 In Iran, the newborn screening forms were 
used to collect data and were kept in screening centres and 












Ministry of Health 2 (10)
Medical University, Department of Health 2 (10)






Family health 2 (10)
Public health 7 (35)
Laboratory Sciences 2 (10)
Education level
Diploma 2 (10)
Associate degree 2 (10)
Bachelor degree 11 (55)
MD/Ph.D 5 (25)
Table 1 Demographic characteristics of the participants
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laboratories. However, there was no electronic system for 
collecting newborn screening data.25 Having reviewed the 
literature, it was revealed that three main areas related to 
the process of data collection were privacy and confidential-
ity, data sources and data transfer tools which are discussed 
below separately.
Privacy and confidentiality
According to the literature review, setting privacy and confi-
dentiality laws and obtaining parents’ informed consent were 
the most common ethical principles in all three countries.26–28 
However, in Australia, privacy and confidentiality policies were 
more complicated to increase the privacy of newborn screen-
ing data. These policies included authorising staff to access 
screening card and to use the electronic system.28 In Iran, the 
document review showed that there was no specific privacy 
and confidentiality plan for the newborn screening data.
Data sources
The findings showed that the health/primary care centres, lab-
oratories and the Ministry of Health/National Health Services 
were the main data sources of newborn screening data in all 
three countries.18,24,29 In America and England, the obstet-
ric and public health centres were other data sources.18,24 
In England and Australia, data were also generated in hos-
pitals to be included in the newborn screening system.18,29 
The results showed that compared to America and England, 
Australia used fewer data sources in the newborn screening 
process. In Iran, the data sources of the newborn screening 
system were health centres, laboratories, hospitals and the 
Ministry of Health.25
Data transfer tools
According to the findings, in America, the newborn screening 
system used more tools to collect relevant data.30 Moreover, 
all three countries used email and electronic health records 
(mother and baby) to collect data.22,23,31 The web-based 
electronic system was used only in America.12,32 In Iran, how-
ever, only phone call and data collection forms were used to 
transfer newborn screening data and there was no electronic 
system to collect data.
Data classification systems
The findings showed that newborn screening data were clas-
sified using textbooks and various systems in America,33 
Australia14 and England.34 In Iran, there was no specific 
classification and nomenclature system used for newborn 
screening data management (Table 2).
Methods of data quality control
The findings showed that in America, assigning a unique serial 
number to the birth certificate and newborn screening card 
and controlling the serial numbers were among the methods 
used to control data quality.35 In England, national numbers 
were used in newborn screening cards along with the barcode 
technology, numbered tags, standard codes for exchanging 
newborn screening data, data dictionary, data standards and 
unique ID numbers in laboratory processes.18 In Australia, the 
main focus was on the development of data dictionary and 
standards.36 However, in Iran, there is no mechanism for con-
trolling the quality of newborn screening data.
DISCUSSION
The newborn screening programme is considered a preven-
tive public health programme in many countries. It provides 
timely information and services to prevent many conse-
quences, such as disability, death and other complications 
of a newborn’s diseases. While in many newborn screen-
ing programmes, less attention has been paid in collecting 
the related data,37 improving the quality of the programme 
is dependent on the systematic data collection of screening 
services.13 The findings of the current study showed that in 
America, Australia and England, newborn screening data are 
managed in a systematic manner. In these countries, in addi-
tion to the manual systems, electronic systems were used to 
manage newborn screening data. In Iran; however, only the 




America England Australia Iran
SNOMED CT  − −
No specific classification and nomenclature 
system is used
LOINC  − −
ICD-10 −  
ICD-9 − − 
ICD-10-CM  − −
ICD-9-CM  − −
Enzyme codes  − −
OMIM codes  − −
Table 2 Data classification and nomenclature systems used in newborn screening data management
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information, date of sampling, information about the primary 
care and the sampling centre, Guthrie paper number and the 
test results were recorded in paper-based records.38
Having compared the status of the newborn screening data 
management in three selected countries, a framework was 
proposed for managing the newborn screening data in Iran. 
The framework included six main components: objectives, 
involved organisations, data elements, data collection pro-
cess, disease classification and the methods of data quality 
control (Figure 1).
Concerning the objectives of the newborn screening pro-
grammes, the findings showed that disease prevention, 
information-based planning, controlling the quality of the 
programme and educating healthcare professionals were 
common in the selected countries. The results are consistent 
with the findings reported by Olivieri39 who showed that the 
objectives of a national registry system for hypothyroidism 
in children were evaluating newborn screening programmes 
and conducting research and epidemiological studies. Also, 
Pitt stated that the secondary objectives of using newborn 
screening cards are quality assurance, detecting other dis-
eases and conducting research.40
Regarding the involved organisations, in Australia, the 
Genetic Association and the Ministry of Health were respon-
sible for managing the newborn screening data. In this coun-
try, the newborn screening data were collected separately in 
each state41; however, in America and England, the newborn 
screening data were collected at the national level.32,34 In 
Iran, the screening data of newborns’ hypothyroidism dis-
ease is collected at the national level and other data are 
collected locally to be reported to the Ministry of Health.25 
Moreover, regarding the number of involved organisations in 
the process of collecting newborn screening data, in America, 
more organisations were involved in the process compared 
to England and Australia. These organisations included 
the screening committee, genetic committee, children with 
hereditary disorders committee, laboratories community, 
information management association and centre for health 
information technology. The results are in line with the state-
ment of American Academy of Pediatrics, in which they noted 
that providing the best newborn screening services depends 
on the interaction between the hospitals, healthcare centres 
and public health organisations.42 Hinman et al.17 reported 
that the Ministry of Health, laboratories, hospitals, health 
houses, legislator organisations and insurance companies 
should be involved in the process of newborn screening. In 
another study, Livingston et al.43 noted that data obtained 
from tracking newborn clinical genetic services are impor-
tant for improving newborn screening programmes, and 
cooperation between genetic services and organisations 
which are responsible for implementing newborn screening 
programmes is necessary. However, In Iran, the Ministry of 
Health is the only organisation responsible for implementing 
newborn screening programmes.25 Therefore, it seems that 
organisational involvement in collecting the newborn screen-
ing data may help to improve health management and deci-
sion making.
Data collection process is another important component of 
a newborn screening process. In England, the data collection 
process started at the birth time by taking the parents’ con-
sent form and taking the baby’s blood sample at the hospital 
or midwifery services. In this process, the department of 
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newborn health records, primary care centres, laboratories 
and specialised groups work together to collect related data. 
Similarly, Hinman et al.17 suggested that the newborn’s fam-
ily, health centres, clinical care coordinators, support ser-
vices, laboratories and hospitals need to be involved in the 
process of screening and data collection. In another study, 
Padilla et al. stated that the current health records in the 
public health sector can be used as a ready mechanism for 
recording the newborn screening data. For example, in the 
Philippines, the newborn screening results are recorded in 
the newborn health record; so that, service providers use the 
results in their preliminary examinations and make decision.6
While collecting the newborn screening data, it is impor-
tant to consider data privacy and confidentiality issues. The 
literature review showed that all three countries paid spe-
cial attention to this issue. According to Botkin et al. taking 
informed consent from parents is necessary before record-
ing a sick newborn’s data in the national registry of newborn 
screening. The researchers believed that parents have the 
right to decide about participating in future research.44 In 
Iran; however, there is no specific plan to assure the privacy 
and confidentiality of newborn screening data. As a result, it 
is necessary to identify different approaches taken by other 
countries to be able to learn and overcome this challenge.
Regarding data sources, Botkin et al. noted that a national 
registry for newborn screening data, newborn’s family, 
healthcare providers at different levels, healthcare centres/
health houses and schools can be considered data sources. 
They believed that a large amount of newborn screening data 
is collected by speaking with parents. They also indicated 
that web-based newborn screening systems are appropriate 
tools for collecting the data.44 However, in Iran, the number of 
data sources is limited to the health centres, laboratories, the 
department of health located in the medical universities and 
the Ministry of Health. Obviously, by paying more attention to 
the newborn screening programme and its related data, data 
sources will be identified to be able to collect more accurate 
and complete data.
In newborn screening programme, not only data sources 
are important but also data sharing and data transfer are of 
high importance to be able to manage diseases in a timely 
manner. Padilla et al. stated that communication tools play 
an important role in tracking sick newborns, especially when 
getting access to families is difficult. They introduced smart-
phones as an appropriate way to educate families to follow 
newborn screening programmes.6 In another study, Therrell 
et al. showed that the newborn screening data, birth records 
and other documents related to public health are integral 
parts of every person’s electronic health record. Therefore, a 
unique ID number of newborn screening samples, like Guthrie 
number, can be used to link patient’s data.35 It is notable that 
using electronic systems is suggested for managing newborn 
screening data because it can support different components 
of the programme, reduce errors and improve effectiveness.6 
However, where the time is crucial, the telephone is still used 
as the first communication tool in many countries. In Iran, 
data transfer tools were the telephone and paper-based 
records. Therefore, more attention should be paid and to 
move forward to use information technology and improve the 
efficiency and effectiveness of such programmes.
An integral part of quantitative studies and a basis for 
scientific conclusions is classification.45 In healthcare, the 
necessity of using classification and nomenclature sys-
tems, such as systematic naming of clinical medical terms 
(SNOMED CT), logical observation codes and identifiers 
(LOINC), ICD-10-CM, ICD-9-CM and enzyme codes for pro-
viding standard laboratory reports and exchanging data in 
electronic systems, such as electronic health records have 
been suggested.24 These systems play an important role in 
organising data and applying obtained knowledge in planning 
and decision making. Moreover, the interaction between dif-
ferent electronic systems depends upon the application of 
data classification and standards. In this regard, Goodwin 
et al.46 suggested that the use of standard terminology and 
coding systems empowers researchers, clinicians and public 
health systems to exchange newborn screening data in vari-
ous states in America. In Iran; however, there was no spe-
cific classification and nomenclature system for managing 
the newborn screening data. Therefore, the use of different 
types of classification and nomenclature standards, such as 
LOINC, and SNOMED CT is suggested to be able to analyse 
and exchange data.
According to the results, in order to control data quality, 
using the national number in the newborn’s screening card, 
barcode technology, numbered tags, standard codes for 
exchanging newborn’s screening data and developing data 
dictionary, standards and unique ID numbers for laboratory 
results were suggested.34–36 The results of the 26th session of 
the Advisory Committee on Heritable Disorders in Newborns 
and Children in Washington showed that using a serial num-
ber on the birth certificate can improve the quality of data in 
the newborn’s screening process. Moreover, the use of the 
unique ID number for the newborn’s screening sample can 
help to link data and health records and facilities patient track-
ing.14 However, in Iran, there was no specific mechanism for 
controlling the quality of newborn’s screening data.
While the framework suggested in the current study includes 
the main components for managing newborn screening data, 
to be able to collect useful data, a collaboration between dif-
ferent organisations and sources of information is required. 
To achieve this, effective communication strategies need to 
be set among the public health, primary care and referral/
specialty services to be assured about the continuity and the 
accessibility of information at the point of need.
LIMITATIONS
Although in this study, a framework was proposed to manage 
newborn screening data in Iran, the study had some limita-
tions. First of all, due to the time and resources restrictions, 
only three countries were selected to identify and compare 
the necessary components of newborn screening data man-
agement. Although, these countries had a long-term experi-
ence in the newborn screening programmes and had moved 
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towards using electronic systems, including more countries 
or comparing the methods of newborn screening data man-
agement in the developing and developed countries may give 
a more complete picture of the experiences gained by differ-
ent countries. The second limitation was related to approving 
the framework by the experts. The framework proposed in 
the current study was formed based on the literature review. 
Further research has been planned to gain the consensus of 
experts about the appropriateness of the framework and its 
components.
CONCLUSION
The newborn screening programme is an integrated part of a 
public health plan which aims to track the status of the new-
born patients and to connect healthcare providers, families 
and related healthcare organisations. In order to manage the 
newborn screening data in Iran, a framework was proposed 
based on the experiences of three selected countries. The 
experiences of the selected countries showed that newborn 
screening activities should be conducted in a structured man-
ner. As a result, the framework had six main components; 
namely, objectives, involved organisations, data elements, 
data collection process, disease classification and the meth-
ods of data quality control. The framework suggested in the 
current study can help to re-organise the process of newborn 
screening with a focus on managing related data. These data 
can be used in conducting research and setting strategies for 
improving the quality of child health in the country.
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